SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,960,920 | -31.9% | 2,821,000 | -1.8% | 1.65% | -21.4% |
| Q2 2023 | $60,110,960 | -26.4% | 2,872,000 | -25.7% | 2.10% | -22.5% |
| Q1 2023 | $81,635,136 | -45.3% | 3,865,300 | -34.1% | 2.71% | -16.1% |
| Q4 2022 | $149,162,450 | +11.1% | 5,861,000 | +4.9% | 3.23% | +18.4% |
| Q3 2022 | $134,253,000 | +28.0% | 5,586,900 | +2.5% | 2.73% | +13.4% |
| Q2 2022 | $104,858,000 | +25.1% | 5,450,000 | +13.0% | 2.41% | +37.9% |
| Q1 2022 | $83,831,000 | -20.6% | 4,823,400 | 0.0% | 1.75% | -22.0% |
| Q4 2021 | $105,584,000 | +14.5% | 4,823,400 | 0.0% | 2.24% | +9.6% |
| Q3 2021 | $92,175,000 | +16.3% | 4,823,400 | +4.5% | 2.04% | -4.7% |
| Q2 2021 | $79,240,000 | -7.9% | 4,615,000 | +20.0% | 2.14% | -9.8% |
| Q1 2021 | $85,997,000 | +16.9% | 3,846,000 | +16.3% | 2.38% | -0.5% |
| Q4 2020 | $73,570,000 | +168.8% | 3,308,000 | +78.4% | 2.39% | +88.2% |
| Q3 2020 | $27,367,000 | +20.9% | 1,854,100 | +21.4% | 1.27% | -12.5% |
| Q2 2020 | $22,636,000 | – | 1,527,400 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $24,631,000 | 16.36% |
| Kynam Capital Management, LP | 2,272,915 | $54,618,000 | 11.51% |
| Frazier Life Sciences Management, L.P. | 3,412,838 | $82,010,000 | 6.32% |
| Foresite Capital Management IV, LLC | 690,000 | $16,581,000 | 5.33% |
| Paradigm Biocapital Advisors LP | 1,085,142 | $26,076,000 | 3.48% |
| ACUTA CAPITAL PARTNERS, LLC | 324,614 | $7,800,000 | 3.36% |
| COMMODORE CAPITAL LP | 738,110 | $17,737,000 | 2.85% |
| SPHERA FUNDS MANAGEMENT LTD. | 822,696 | $19,769,000 | 2.74% |
| Avidity Partners Management LP | 5,586,900 | $134,253,000 | 2.73% |
| HealthCor Management, L.P. | 859,240 | $20,648,000 | 2.58% |